Magazine: Keep it cool
Pharma is being pulled in every direction at once: more complex, more connected, more uncertain. Yet the industry keeps moving,…
Pharma is being pulled in every direction at once: more complex, more connected, more uncertain. Yet the industry keeps moving,…
Aptar Pharma is collaborating with Macquarie University in a partnership that will see the drug delivery specialist and Australian institution…
Drug delivery specialist Aptar Pharma is collaborating with Aceso Therapeutics to advance development for the latter’s ACT-101 – an inhalable…
Lantheus Holdings’ radiodiagnostic agent for identifying tau pathology in adult patients under evaluation for Alzheimer’s disease has secured US Food…
Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal. Varun…
A combination of US government incentives, supply chain disruptions, and geopolitical tensions are prompting increased investment in US manufacturing. In…
Johnson and Johnson (J&J) has achieved Q2 revenues totalling around $25.3bn, representing a year-over-year (YoY) uptick of 6.6%, with the…
The US Food and Drug Administration (FDA) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) will more formally…
In recent years, the context surrounding the pharmaceutical industry has been growing towards digitalisation of processes. Manual operations in pharma…
UK health secretary Wes Streeting has resigned, citing a ‘loss of faith’ in the Labour party’s leadership under Prime Minister…